Evidence map›Paper›PMID 32963589›Full record

ArticleGut pathogens2020

Plasmid mediated colistin resistant

Bijaya Muktan, Upendra Thapa Shrestha, Binod Dhungel, Bagish Chandra Mishra, Nabaraj Shrestha, Nabaraj Adhikari, Megha Raj Banjara, Bipin Adhikari, Komal Raj Rijal, Prakash Ghimire

Open access · goldAbstract read
In one paragraph

Article in Gut pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Detection of plasmid-mediatedInfectious diseases & immunity · 2025
    Article
  4. Article
  5. Article
  6. Prevalence ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mobile Colistin Resistance (Antibiotics (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Epidemiology and zoonotic transmission ofFrontiers in microbiology · 2023
    Article
  15. Article
  16. Review
  17. Worldwide Prevalence ofPathogens (Basel, Switzerland) · 2022
    Review
  18. Detection of NDM Variants (Infection and drug resistance · 2022
    Article
  19. Genetic Diversity ofBioMed research international · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Bijaya Muktan *Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Upendra Thapa Shrestha *Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Binod DhungelCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Bagish Chandra MishraKantipur Hospital Pvt. Ltd., Tinkune, Kathmandu, Nepal.
Nabaraj ShresthaCentral Veterinary Laboratory, Ministry of Agriculture, Land Management and Cooperatives, Government of Nepal, Tripureshwor, Kathmandu, Nepal.
Nabaraj AdhikariCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Megha Raj BanjaraCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Bipin AdhikariCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Komal Raj RijalCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.ORCID 0000-0001-6281-8236
Prakash GhimireCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Tribhuvan University · NPGovernment of Nepal · NPKanti Children's Hospital · NPUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmid-mediated resistance to the last-resort drugs: carbapenems and colistin is an emerging public health threat. The studies on the prevalence and co-expression of resistant genes among livestock and human pathogens are rare in Nepal. This is the first study in Nepal exploring the prevalence and co-existence of colistin resistance gene,

methodsA total of 240 rectal swabs from chickens of five different poultry farms of Kathmandu valley and 705 mid-stream urine samples from human subjects attending Kantipur Hospital, Kathmandu were collected between August, 2018 and March, 2019. Rectal swabs and urine specimens were cultured.

resultsOf the total samples analyzed,

conclusionsThe high prevalence of colistin and carbapenem resistant genes, and their co-existence in plasmid DNA of

Indexed as

Colistin resistant E. colimcr-1MDROXA-48Polymerase chain reaction

Identifiers

PMID32963589
PMCPMC7499862
OpenAlexW3087542245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.